ReviewCurrent epidemiology reports2025
Breaking down the Dyslipidemia-Stroke Relationship in Southeast Asian American Subgroups: Advancing Toward Cardiovascular Health Equity.
Review in Current epidemiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Purpose of Review: Southeast Asian (SEA) American populations-including Filipino, Vietnamese, Cambodian, Laotian, Burmese, and Hmong communities-experience disproportionate burdens of dyslipidemia and cardiovascular disease in the United States (U.S.) population. Despite these disparities, SEA Americans remain underrepresented in cardiovascular research and epidemiology. This review synthesizes U.S.-based epidemiologic, clinical, and community-level evidence on dyslipidemia and stroke across SEA subgroups, emphasizing how aggregated data obscure subgroup-specific disparities. Recent Findings: Disaggregated data reveal that Filipino and Vietnamese adults-among the most studied SEA subgroups-exhibit high rates of elevated low-density lipoprotein cholesterol and hypertriglyceridemia, aligning with increased ischemic stroke prevalence, higher age-standardized cerebrovascular mortality, and greater years of potential life lost. Hemorrhagic stroke mortality is also comparatively high in these groups. In contrast, data for Cambodian, Laotian, Hmong, and Burmese Americans remain sparse, limiting risk characterization. Emerging evidence highlights that cardiometabolic disorders in SEA populations reflect heterogeneous and multifactorial influences, including genetic variability in statin metabolism, cultural health beliefs, psychosocial stressors, and systemic barriers to preventive care. Summary: Cardiovascular risk in SEA American populations is shaped by the interplay of biological and social determinants of health. Aggregating diverse Asian subgroups into a single racial category masks heterogeneity, widens knowledge gaps, and perpetuates inequities in care. Advancing cardiovascular health equity requires intentional inclusion of underrepresented SEA subgroups in clinical research, systematic data disaggregation, and culturally responsive approaches to lipid management and stroke prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.